Jundishapur Journal of Microbiology

Published by: Kowsar

The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey

Derya Keten 1 , Mehmet Emin Ova 2 , Hamit Sirri Keten 3 , * , Alper Keten 4 , Evrim Gulderen 1 , Seray Tumer 5 , Ahmet Caliskan 5 and Suleyman Kulotu 1
Authors Information
1 Department of Clinical Microbiology and Infectious Diseases, Necip Fazil City Hospital, Kahramanmaras, Turkey
2 Kahramanmaras Closed Prison, General Practice, Kahramanmaras, Turkey
3 Department of Family Medicine, Kurtul Family Health Center, Kahramanmaras, Turkey
4 Council of Forensic Medicine, Kahramanmaras Branch, Kahramanmaras, Turkey
5 Department of Microbiology, Necip Fazil City Hospital, Kahramanmaras, Turkey
Article information
  • Jundishapur Journal of Microbiology: February 01, 2016, 9 (2); e31598
  • Published Online: February 13, 2016
  • Article Type: Research Article
  • Received: July 16, 2015
  • Revised: December 8, 2015
  • Accepted: December 16, 2015
  • DOI: 10.5812/jjm.31598

To Cite: Keten D, Emin Ova M, Sirri Keten H, Keten A, Gulderen E, et al. The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey, Jundishapur J Microbiol. 2016 ; 9(2):e31598. doi: 10.5812/jjm.31598.

Abstract
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Dienstag JL, Delemos AS. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2015; : 1439-68
  • 2. Reekie JM, Levy MH, Richards AH, Wake CJ, Siddall DA, Beasley HM, et al. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010. Med J Aust. 2014; 200(5): 277-80[PubMed]
  • 3. Tumer A. What is AIDS? 2013;
  • 4. Alvarez KJ, Befus M, Herzig CT, Larson E. Prevalence and correlates of hepatitis C virus infection among inmates at two New York State correctional facilities. J Infect Public Health. 2014; 7(6): 517-21[DOI][PubMed]
  • 5. Lemberg BD, Shaw-Stiffel TA. Hepatic disease in injection drug users. Infect Dis Clin North Am. 2002; 16(3): 667-79[PubMed]
  • 6. Murrill CS, Weeks H, Castrucci BC, Weinstock HS, Bell BP, Spruill C, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002; 92(3): 385-7[PubMed]
  • 7. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791): 571-83[DOI][PubMed]
  • 8. Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, et al. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health. 2008; 62(4): 305-13[DOI][PubMed]
  • 9. Kinner SA, Jenkinson R, Gouillou M, Milloy MJ. High-risk drug-use practices among a large sample of Australian prisoners. Drug Alcohol Depend. 2012; 126(1-2): 156-60[DOI][PubMed]
  • 10. Pollini RA, Alvelais J, Gallardo M, Vera A, Lozada R, Magis-Rodriquez C, et al. The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico. Drug Alcohol Depend. 2009; 103(1-2): 52-8[DOI][PubMed]
  • 11. Bretana NA, Boelen L, Bull R, Teutsch S, White PA, Lloyd AR, et al. Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012. Emerg Infect Dis. 2015; 21(5): 765-74[DOI][PubMed]
  • 12. Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011; 377(9769): 956-65[DOI][PubMed]
  • 13. Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013; 58(4): 1215-24[DOI][PubMed]
  • 14. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepat Mon. 2011; 11(1): 19-22[PubMed]
  • 15. Nokhodian Z, Yaran M, Adibi P, Kassaian N, Meshkati M, Ataei B. Seroprevalence of hepatitis B markers among incarcerated intravenous drug users. J Res Med Sci. 2014; 19-6[PubMed]
  • 16. Shirani K, Nokhodian Z, Kassaian N, Adibi P, Naeini AE, Ataei B. The prevalence of isolated hepatitis B core antibody and its related risk factors among male injected drug users in Isfahan prisons. Adv Biomed Res. 2015; 4: 17[DOI][PubMed]
  • 17. Azbel L, Wickersham JA, Wegman MP, Polonsky M, Suleymanov M, Ismayilov R, et al. Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan. Drug Alcohol Depend. 2015; 151: 68-75[DOI][PubMed]
  • 18. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4): 1333-42[DOI][PubMed]
  • 19. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008; 48(1): 148-62[DOI][PubMed]
  • 20. Tozun N, Ozdogan OC, Cakaloglu Y, Idilman R, Karasu Z, Akarca US, et al. A nationwide prevalence study and risk factors for hepatitis A, B, C and D infections in Turkey. Hepatology. 2010; 52: 697
  • 21. Mıstık, R. . viral Hepatitis 2013. 2013;
  • 22. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015; 61(1): 77-87[DOI][PubMed]
  • 23. Sanlidag T, Akcali S, Ozbakkaloglu B, Ertekin D, Akduman E. [Distribution of hepatitis C virus genotypes in Manisa region, Turkey]. Mikrobiyol Bul. 2009; 43(4): 613-8[PubMed]
  • 24. Aktas E, Ogedey ED, Kulah C, Begendik Comert F. [Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey]. Mikrobiyol Bul. 2010; 44(4): 647-50[PubMed]
  • 25. Tezcan S, Ulger M, Aslan G, Yaras S, Altintas E, Sezgin O, et al. [Determination of hepatitis C virus genotype distribution in Mersin province, Turkey]. Mikrobiyol Bul. 2013; 47(2): 332-8[PubMed]
  • 26. Yildiz E, Oztan A, Sar F, Pinarbasi E, Cetin-Atalay R, Akkiz H, et al. Molecular characterization of a full genome Turkish hepatitis C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey. Virus Genes. 2002; 25(2): 169-77[PubMed]
  • 27. Abacioglu YH, Davidson F, Tuncer S, Yap PL, Ustacelebi S, Yulug N, et al. The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat. 1995; 2(6): 297-301[PubMed]
  • 28. Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, et al. Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World J Gastroenterol. 2008; 14(8): 1237-43[PubMed]
  • 29. Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol. 2000; 60(2): 122-5[PubMed]
  • 30. Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat. 2005; 12(4): 405-13[DOI][PubMed]
  • 31. Bourliere M, Halfon P, Portal I. [Treatment of chronic hepatitis C in special groups]. Gastroenterol Clin Biol. 2002; 26 Spec No 2-47[PubMed]
  • 32. de Vries MJ, te Rijdt B, van Nieuwkerk CM. Genotype distribution amongst hepatitis C patients in The Netherlands. Neth J Med. 2006; 64(4): 109-13[PubMed]
  • 33. Mohammad Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol. 2005; 11(26): 4085-9[PubMed]
  • 34. Massad E, Rozman M, Azevedo RS, Silveira AS, Takey K, Yamamoto YI, et al. Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners: preponderance of parenteral transmission. Eur J Epidemiol. 1999; 15(5): 439-45[PubMed]
  • 35. Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, et al. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect. 2000; 40(2): 176-83[PubMed]
  • 36. Okie S. Sex, drugs, prisons, and HIV. N Engl J Med. 2007; 356(2): 105-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments